Julia Aijun Wang - 10 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
Chief Financial Officer, EVP
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang
Issuer symbol
LH
Transactions as of
10 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 15:41:51 UTC
Previous filing
10 Feb 2026
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wang Julia Aijun Chief Financial Officer, EVP 531 SOUTH SPRING STREET, BURLINGTON /s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang 12 Feb 2026 0001860279

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Award $0 +7,100 $0.000000 7,100 10 Feb 2026 Common Stock 7,100 $284.50 Direct F1, F2
transaction LH Restricted Stock Unit Award $0 +2,350 +68% $0.000000 5,824 10 Feb 2026 Common Stock 2,350 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
F2 The option vests in three equal annual installments beginning on the date reflected in this column.
F3 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F4 The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.